查看購物車
  • Simplified Chinese
  • English
  • Japanese
北美腸內和腸外醫療營養市場預測至 2028 年 - 按適應症、營養類型、形式、產品類型、給藥途徑、年齡層和配銷通路進行的區域分析
市場調查報告書
商品編碼
1375202

北美腸內和腸外醫療營養市場預測至 2028 年 - 按適應症、營養類型、形式、產品類型、給藥途徑、年齡層和配銷通路進行的區域分析

North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication, Nutrition Type, Form, Product Type, Route of Administration, Age Group, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 217 Pages | 訂單完成後即時交付

價格

北美腸內和腸外醫療營養市場預計將從2023年的804998萬美元成長到2028年的1103078萬美元。預計2023年至2028年年複合成長率為6.5%。

胃腸道疾病盛行率上升推動北美腸內和腸外醫療營養市場

克隆氏症、腸阻塞、潰瘍性結腸炎、短腸症候群、顯微鏡下結腸炎和某些癌症是胃腸道疾病的一些例子。

根據 2019 年全球疾病負擔研究，2019 年全球記錄了約 490 萬例發炎性腸道疾病 (IBD) 病例；中國（911,405例）和美國（762,890例）的病例數最多，盛行率分別為每10萬人中66.9例和245.3例。克隆氏症和潰瘍性結腸炎是兩種常見的 IBD。克隆氏症是一種複雜的慢性疾病，主要影響消化系統。這是北美最常見的疾病。此外，每年每 100 萬人中約有 3 人患有短腸症候群 (SBS)。根據 2020 年發表的題為「了解短腸症候群：現況與未來展望」的文章，SBS 的盛行率在過去 40 年中增加了兩倍多。在美國，盛行率約為每百萬人 30 例。

患有胃腸道疾病的患者營養惡化的風險較高，因為他們被要求在接受診斷測試之前禁食。他們也可能因治療性飲食限制而面臨營養惡化，以及厭食症或營養需求改變引起的食慾不振，這可能是疾病本身造成的。因此，建議對胃腸道疾病患者進行醫學營養，因為這些患者無法攝取食物。因此，優選腸內和腸外途徑來為它們提供必需的營養。腸內餵食是指直接經由口腔或經由消化道（口腔到胃/小腸，然後肛門）的管子攝取食物營養。這種類型的營養優選為患有慢性疾病的患者提供治療支持，例如神經系統疾病、胃腸道疾病和遺傳性代謝疾病。有些人可能不適合插管，這使得滿足他們的卡路里和營養需求變得困難。在這種情況下，優選腸外營養，以確保他們的身體保持水分並滿足維持身體健康和功能所需的熱量和其他營養攝取量。當患者因癌症和影響胃腸道的慢性疾病等疾病而無法滿足營養需求時，需要腸外營養。這種營養是大多數嚴重 SBS 患者治療的基石。因此，胃腸道疾病盛行率的上升推動了北美腸內和腸外醫療營養市場的成長。

北美腸內及腸外醫療營養市場概況

北美腸內和腸外醫療營養市場已細分為美國和加拿大。到2022年，美國將佔據更大的市場佔有率。慢性病盛行率的上升、市場參與者不斷發展的策略發展以及對腸內和腸外營養的日益偏好都有助於該地區的市場進步。此外，人們對醫療營養（例如管飼）在治療慢性疾病方面的益處的了解不斷增加，進一步促進了市場的成長。

北美腸內及腸外醫療營養市場收入及 2028 年預測（百萬美元）

北美腸內和腸外醫療營養市場細分

北美腸內和腸外醫療營養市場分為適應症、營養類型、形式、產品類型、給藥途徑、年齡層、配銷通路和國家。

根據適應症，北美腸內和腸外醫療營養市場分為老年人、胃腸道疾病、糖尿病、癌症、呼吸系統疾病、阿茲海默症、失智症、腎臟疾病、肝衰竭、covid-19後和其他適應症。 2023年，老年族群在北美腸內和腸外醫療營養市場中佔據最大佔有率。胃腸道疾病分為IBD、IBS等。

根據營養類型，北美腸內和腸外醫療營養市場分為補充來源和單一來源。 2023年，補充品細分市場在北美腸內和腸外醫療營養市場中佔有更大佔有率。

根據形式，北美腸內和腸外醫療營養市場分為液體、粉末和半固體。 2023年，液體細分市場佔據北美腸內和腸外醫療營養市場的最大佔有率。

根據產品類型，北美腸內和腸外醫療營養市場分為一般和特定疾病。 2023年，普通細分市場在北美腸內和腸外醫療營養市場中佔據最大佔有率。

根據給藥途徑，北美腸內和腸外醫療營養市場分為口服、管飼和腸外。 2023年，腸外細分市場佔據北美腸內和腸外醫療營養市場的最大佔有率。

依年齡層，北美腸內和腸外醫療營養市場分為60歲以上、18-60歲、3-18歲及3歲以下。 2023年，60歲以上細分市場佔據北美腸內和腸外醫療營養市場的最大佔有率。

根據配銷通路，北美腸內和腸外醫療營養市場分為醫院藥房、零售店、電子商務等。 2023年，醫院藥局部門在北美腸內和腸外醫療營養市場中佔據最大佔有率

根據國家/地區，北美腸內和腸外醫療營養市場分為美國和加拿大。 2023年，美國在北美腸內和腸外醫療營養市場佔有率中佔據主導地位。

雅培實驗室； B.布勞恩公司；百特國際公司；費森尤斯·卡比股份公司；麥迪卡營養公司； Medtrition 公司；雀巢公司；紐迪西亞國際有限公司；和 Nutrisens SAS 是北美腸內和腸外醫療營養市場的領先公司。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 北美腸內和腸外醫療營養市場 - 按適應症
    • 北美腸內和腸外醫療營養市場 - 按營養類型
    • 北美腸內和腸外醫療營養市場 - 按形式
    • 北美腸內和腸外醫療營養市場 - 按產品類型
    • 北美腸內和腸外醫療營養市場 - 按給藥途徑
    • 北美腸內和腸外醫療營養市場 - 按年齡層
    • 北美腸內和腸外醫療營養市場 - 按配銷通路
    • 北美腸內和腸外醫療營養市場 - 按國家/地區

第 2 章：要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美腸內和腸外醫療營養市場 - 市場格局

  • 概述
  • 北美 PEST 分析
  • 專家意見
  • 能量含量分析
    • 低於 1.5 kcal/ml
    • 等於 1.5 kcal/ml
    • 低於2kcal/ml：
    • 等於或高於2kcal/ml：

第 5 章：北美腸內和腸外醫療營養市場 - 主要市場動態

  • 市場促進因素
    • 胃腸道疾病盛行率上升
    • 營養不良和早產病例增加
  • 市場限制
    • 與腸內和腸外餵食系統相關的機械、胃腸道和代謝併發症，以及與導管放置相關的限制
  • 市場機會
    • 公司不斷推出策略舉措
  • 未來的趨勢
    • 特定配方和植物性營養產品
  • 影響分析

第 6 章：腸內和腸外醫療營養市場 - 北美分析

  • 北美腸內及腸外醫療營養市場收入預測與分析

第 7 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 按適應症

  • 概述
  • 北美腸內和腸外醫療營養市場收入佔有率，按適應症 2022 年和 2028 年 (%)
  • 老年
  • 胃腸道疾病
  • 糖尿病
  • 癌症
  • 呼吸系統疾病
  • 阿茲海默氏症
  • 失智
  • 腎臟疾病
  • 肝衰竭
  • 新冠肺炎 (COVID-19) 後
  • 其他適應症

第 8 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 按營養類型

  • 概述
  • 北美腸內和腸外醫療營養市場收入佔有率，按營養類型 2022 年和 2028 年 (%)
  • 補充
  • 唯一來源

第 9 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 按表格

  • 概述
  • 北美腸內和腸外醫療營養市場收入佔有率，按 2022 年和 2028 年表格 (%)
  • 液體
  • 粉末
  • 半固態

第 10 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 按產品類型

  • 概述
  • 2022 年和 2028 年北美腸內和腸外醫療營養市場收入佔有率（按產品類型分類）
  • 一般的
  • 特定疾病

第 11 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 按給藥途徑

  • 概述
  • 北美腸內和腸外醫療營養市場收入佔有率，按給藥途徑 2022 年和 2028 年 (%)
  • 口服
  • 管飼
  • 注射用

第 12 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 按年齡層

  • 概述
  • 北美腸內和腸外醫療營養市場收入佔有率，按年齡層 2022 年和 2028 年 (%)
  • 60歲以上
  • -60年
  • 3-18歲
  • 3歲以下

第 13 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 按配銷通路

  • 概述
  • 北美腸內和腸外醫療營養市場收入佔有率，按配銷通路2022 年和 2028 年 (%)
  • 醫院藥房
  • 零售店
  • 電子商務
  • 其他

第 14 章：北美腸內和腸外醫療營養市場 - 收入和 2028 年預測 - 國家分析

  • 概述

第 15 章：北美腸內和腸外醫療營養市場 - 產業格局

  • 概述
  • 北美腸內和腸外醫療營養市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 16 章：公司簡介

  • Abbott Laboratories
  • Nestle SA
  • Nutricia International BV
  • Medtrition Inc
  • Fresenius Kabi AG
  • B. Braun SE
  • Nutrisens SAS
  • Baxter International Inc
  • Medica Nutrition Inc

第 17 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: BMIRE00028875

The North America enteral and parenteral medical nutrition market is expected to grow from US$ 8,049.98 million in 2023 to US$ 11,030.78 million by 2028. It is estimated to grow at a CAGR of 6.5% from 2023 to 2028.

Rise in Prevalence of Gastrointestinal Diseases Fuels North America Enteral and Parenteral Medical Nutrition Market

Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancers are a few examples of gastrointestinal diseases.

Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; China (911,405) and the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn's disease and ulcerative colitis are two of the commonly diagnosed IBDs. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence was ~30 cases per million in the US.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirement, which can be a result of the disease itself. Thus, medical nutrition is recommended for gastrointestinal disease patients as these patients cannot ingest food. Thus, the enteral and parenteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to food nutrition intake directly through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Some people may not show compatibility toward tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs due to diseases, such as cancer and chronic diseases affecting the gastrointestinal tract. This type of nutrition is the cornerstone of therapy for most patients with severe SBS. Therefore, the elevating prevalence of gastrointestinal diseases drives the growth of the North America enteral and parenteral medical nutrition market.

North America Enteral and Parenteral Medical Nutrition Market Overview

The enteral and parenteral medical nutrition market in North America has been segmented into the US and Canada. The US held a larger share of the market in 2022. The rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral and parenteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions further contributes to the market growth.

North America Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

North America Enteral and Parenteral Medical Nutrition Market Segmentation

The North America enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.

Based on indication, the North America enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer's disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.

Based on nutrition type, the North America enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the North America enteral and parenteral medical nutrition market in 2023.

Based on form, the North America enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on product type, the North America enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on route of administration, the North America enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on age group, the North America enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on distribution channel, the North America enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023

Based on country, the North America enteral and parenteral medical nutrition market is segmented into the US and Canada. The US dominated the share of the North America enteral and parenteral medical nutrition market in 2023.

Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Medica Nutrition Inc; Medtrition Inc; Nestle SA; Nutricia International BV; and Nutrisens SAS are some of the leading companies operating in the North America enteral and parenteral medical nutrition market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America enteral and parenteral medical nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Enteral and Parenteral Medical Nutrition Market - By Indication
    • 1.3.2 North America Enteral and Parenteral Medical Nutrition Market - By Nutrition Type
    • 1.3.3 North America Enteral and Parenteral Medical Nutrition Market - By Form
    • 1.3.4 North America Enteral and Parenteral Medical Nutrition Market - By Product Type
    • 1.3.5 North America Enteral and Parenteral Medical Nutrition Market - By Route of Administration
    • 1.3.6 North America Enteral and Parenteral Medical Nutrition Market - By Age Group
    • 1.3.7 North America Enteral and Parenteral Medical Nutrition Market - By Distribution Channel
    • 1.3.8 North America Enteral and Parenteral Medical Nutrition Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Enteral and Parenteral Medical Nutrition Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Experts Opinion
  • 4.4 Energy Content Analysis
    • 4.4.1 Lower than 1.5 kcal/ml
    • 4.4.2 Equals to 1.5 kcal/ml
    • 4.4.3 Lower than 2kcal/ml:
    • 4.4.4 Equal to or Higher than 2kcal/ml:

5. North America Enteral and Parenteral Medical Nutrition Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 5.1.2 Increasing Cases of Malnutrition and Premature Births
  • 5.2 Market Restraints
    • 5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Companies
  • 5.4 Future Trends
    • 5.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 5.5 Impact Analysis

6. Enteral and Parenteral Medical Nutrition Market - North America Analysis

  • 6.1 North America Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis

7. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Indication

  • 7.1 Overview
  • 7.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
  • 7.3 Elderly
    • 7.3.1 Overview
    • 7.3.2 Elderly: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
  • 7.4 Gastrointestinal Disorders
    • 7.4.1 Overview
    • 7.4.2 Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
    • 7.4.3 Inflammatory Bowel Disease
      • 7.4.3.1 Overview
      • 7.4.3.2 IBD: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.3.2.1 North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
    • 7.4.4 Irritable Bowel Syndrome
      • 7.4.4.1 Overview
      • 7.4.4.2 IBS: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.4.2.1 North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
    • 7.4.5 Others
      • 7.4.5.1 Overview
      • 7.4.5.2 Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.5.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
  • 7.5 Diabetes
    • 7.5.1 Overview
    • 7.5.2 Diabetes: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
  • 7.6 Cancer
    • 7.6.1 Overview
    • 7.6.2 Cancer: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
  • 7.7 Respiratory Disorders
    • 7.7.1 Overview
    • 7.7.2 Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.7.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
  • 7.8 Alzheimer's Disease
    • 7.8.1 Overview
    • 7.8.2 Alzheimer's Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
  • 7.9 Dementia
    • 7.9.1 Overview
    • 7.9.2 Dementia: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.9.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
  • 7.10 Renal Disease
    • 7.10.1 Overview
    • 7.10.2 Renal Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.10.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
  • 7.11 Liver Failure
    • 7.11.1 Overview
    • 7.11.2 Liver Failure: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.11.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
  • 7.12 Post COVID-19
    • 7.12.1 Overview
    • 7.12.2 Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.12.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
  • 7.13 Other Indications
    • 7.13.1 Overview
    • 7.13.2 Other Indications: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.13.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)

8. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Nutrition Type

  • 8.1 Overview
  • 8.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
  • 8.3 Supplemental
    • 8.3.1 Overview
    • 8.3.2 Supplemental: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Sole Source
    • 8.4.1 Overview
    • 8.4.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Form

  • 9.1 Overview
  • 9.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
  • 9.3 Liquid
    • 9.3.1 Overview
    • 9.3.2 Liquid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Powder
    • 9.4.1 Overview
    • 9.4.2 Powder: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Semi-Solid
    • 9.5.1 Overview
    • 9.5.2 Semi-Solid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Product Type

  • 10.1 Overview
  • 10.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
  • 10.3 General
    • 10.3.1 Overview
    • 10.3.2 General: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Disease Specific
    • 10.4.1 Overview
    • 10.4.2 Disease Specific: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Route of Administration

  • 11.1 Overview
  • 11.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
  • 11.3 Oral
    • 11.3.1 Overview
    • 11.3.2 Oral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Tube Feed
    • 11.4.1 Overview
    • 11.4.2 Tube Feed: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Parenteral
    • 11.5.1 Overview
    • 11.5.2 Parenteral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

12. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Age Group

  • 12.1 Overview
  • 12.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
  • 12.3 Above 60 Years
    • 12.3.1 Overview
    • 12.3.2 Above 60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.4-60 Years
    • 12.4.1 Overview
    • 12.4.2-60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.5 3-18 Years
    • 12.5.1 Overview
    • 12.5.2 3-18 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.6 Below 3 Years
    • 12.6.1 Overview
    • 12.6.2 Below 3 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

13. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Distribution Channel

  • 13.1 Overview
  • 13.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
  • 13.3 Hospital Pharmacies
    • 13.3.1 Overview
    • 13.3.2 Hospital Pharmacies: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.4 Retail Stores
    • 13.4.1 Overview
    • 13.4.2 Retail Stores: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.5 E-Commerce
    • 13.5.1 Overview
    • 13.5.2 E-Commerce: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.6 Others
    • 13.6.1 Overview
    • 13.6.2 Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

14. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - Country Analysis

  • 14.1 Overview
      • 14.1.1.1 US: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.1.1 Overview
        • 14.1.1.1.2 US: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.1.3 US: North America Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
        • 14.1.1.1.3.1 US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
        • 14.1.1.1.3.2 US: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form
        • 14.1.1.1.3.3 US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.3.1 US: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.3.2 US: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.3.3 US: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.4 US: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.5 US: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.6 US: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.7 US: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.8 US: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.9 US: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.10 US: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.11 US: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.12 US: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.4 US: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
        • 14.1.1.1.5 US: North America Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.6 US: North America Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
        • 14.1.1.1.7 US: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
        • 14.1.1.1.8 US: North America Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
        • 14.1.1.1.9 US: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
      • 14.1.1.2 Canada: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.2.1 Overview
        • 14.1.1.2.2 Canada: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.2.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
        • 14.1.1.2.3.1 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
        • 14.1.1.2.3.2 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3.1 Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3.2 Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.4 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.5 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.6 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.7 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.8 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.9 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.10 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.11 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.12 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.4 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
        • 14.1.1.2.5 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.6 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
        • 14.1.1.2.7 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
        • 14.1.1.2.8 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
        • 14.1.1.2.9 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)

15. North America Enteral and Parenteral Medical Nutrition Market - Industry Landscape

  • 15.1 Overview
  • 15.2 Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
  • 15.3 Inorganic Growth Strategies
    • 15.3.1 Overview
  • 15.4 Organic Growth Strategies
    • 15.4.1 Overview

16. Company Profiles

  • 16.1 Abbott Laboratories
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Nestle SA
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Nutricia International BV
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Medtrition Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 Fresenius Kabi AG
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 B. Braun SE
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Nutrisens SAS
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Baxter International Inc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Medica Nutrition Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments

17. Appendix

  • 17.1 About The Insight Partners
  • 17.2 Glossary of Terms

List Of Tables

  • Table 1. North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America Enteral and Parenteral Medical Nutrition Market, For Others by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. US: North America Enteral and Parenteral Medical Nutrition Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. US: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. US: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. US: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. US: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. US: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. US: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. US: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. US: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. US: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. US: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. US: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. US: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. US: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. US: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. US: North America Enteral and Parenteral Medical Nutrition Market, by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. US: North America Enteral and Parenteral Medical Nutrition Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. US: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. US: North America Enteral and Parenteral Medical Nutrition Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. US: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Recent Inorganic Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
  • Table 60. Recent Organic Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
  • Table 61. Glossary of Terms

List Of Figures

  • Figure 1. North America Enteral and Parenteral Medical Nutrition Market Segmentation
  • Figure 2. North America Enteral and Parenteral Medical Nutrition Market, By Country
  • Figure 3. North America Enteral and Parenteral Medical Nutrition Market Overview
  • Figure 4. Elderly Segment Held Largest Share of Indication Segment in North America Enteral and Parenteral Medical Nutrition Market
  • Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 7. North America: PEST Analysis
  • Figure 8. Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. North America Enteral and Parenteral Medical Nutrition Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
  • Figure 12. Elderly: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. IBD: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. IBS: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Diabetes: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Cancer: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Alzheimer's Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Dementia: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Renal Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Liver Failure: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Other Indications: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
  • Figure 27. Supplemental: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Sole Source: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
  • Figure 30. Liquid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Powder: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Semi-Solid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
  • Figure 34. General: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Disease Specific: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
  • Figure 37. Oral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Tube Feed: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Parenteral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
  • Figure 41. Above 60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42.-60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. 3-18 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Below 3 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
  • Figure 46. Hospital Pharmacies: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Retail Stores: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. E-Commerce: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. North America Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 51. North America Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 52. US: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Canada: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market